Lab Community "Extremely Concerned" About Patient Access to Testing If FDA Regulates Lab-Developed Tests
ARUP LaboratoriesNearly 85% of respondents to an ARUP Laboratories survey on the impact of the FDA's proposed rule to regulate laboratory-developed tests (LDTs) believe the proposal will hurt their laboratories and, ultimately, patient care.